Artificial Intelligence-Powered Seizure Prediction Wearable Global Market Report 2025

The artificial intelligence-powered seizure prediction wearable market size has grown exponentially in recent years. It will grow from $1.15 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. Growth during the historic period can be attributed to the rising prevalence of epilepsy, increasing adoption of wearable health monitoring devices, growing public awareness of neurological disorders, higher demand for personalized healthcare solutions, and the increasing occurrence of drug-resistant epilepsy.

The artificial intelligence-powered seizure prediction wearable market size is expected to see exponential growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 22.4%. Growth in the forecast period can be attributed to the expanding clinical validation of AI-based seizure prediction, increasing use of remote patient monitoring platforms, growing integration of cloud-based analytics in healthcare wearables, rising prevalence of neurological disorders, and increasing adoption of home-based and remote monitoring systems. Major trends anticipated during this period include advancements in AI algorithm development, innovations in EEG signal processing, progress in real-time neuro-monitoring sensor technologies, advancements in non-invasive monitoring methods, and the evolution of data-driven neurological modeling.

The rising prevalence of neurological disorders is expected to drive the growth of the artificial intelligence-powered seizure prediction wearable market in the coming years. Neurological disorders are conditions that impair the normal functioning of the brain, spinal cord, or nerves. The increase in these disorders is largely attributed to aging populations, which face a higher risk of neurodegenerative diseases and related complications. AI-powered seizure prediction wearables assist in managing neurological disorders by continuously monitoring physiological signals and using artificial intelligence to forecast seizures, enabling timely intervention and improving patient safety. For example, in April 2024, the National Library of Medicine, a US-based medical library, reported that about 6.9 million Americans aged 65 and above were living with Alzheimer’s dementia, a figure projected to reach 13.8 million by 2060. Therefore, the growing prevalence of neurological disorders is contributing to the expansion of the artificial intelligence-powered seizure prediction wearable market.

Companies operating in the artificial intelligence-powered seizure prediction wearable market are increasingly developing advanced wearable solutions that integrate AI and real-time data analytics to improve seizure prediction and enhance patient safety. These next-generation wearables combine sensors with AI-driven algorithms to continuously analyze physiological data, enabling accurate detection and timely alerts for potential seizure activity. For instance, in February 2024, Empatica Inc., a US-based company spun out from the MIT Media Lab, introduced the EpiMonitor epilepsy monitoring system for real-time seizure detection and alerts. This device detects generalized tonic-clonic seizures with 98 percent accuracy, provides real-time alerts to caregivers, and offers up to seven days of battery life. It also tracks activity, sleep, and other health parameters, supporting better clinical management and empowering patients with continuous monitoring and health insights.

In February 2025, BrainChip Holding Limited, an Australia-based technology company, partnered with Onsor Technologies LLC to develop AI-powered smart glasses capable of predicting epileptic seizures. The partnership aims to provide real-time alerts, enhance safety, and improve the overall quality of life for individuals living with epilepsy. Onsor Technologies LLC, based in Oman, is a technology company specializing in artificial intelligence-powered seizure prediction wearables.

Major players in the artificial intelligence-powered seizure prediction wearable market are Clarrio Health Technologies Ltd., Stevens Institute of Technology, BioSerenity, CeriBell Inc., Seer Medical Pty Ltd., SmartMonitor Inc., Empatica Inc., AMG Detection, Blink Energy Services, Epitel Inc., EpiWatch Inc., mjn.cat, Neurava Inc., Neureka, NightWatch, Onsor Technologies LLC, EpiCare, EpiHealth, NeuroHelp Ltd., and SeizAlarm.

North America was the largest region in the artificial intelligence-powered seizure prediction wearable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence-powered seizure prediction wearable report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence-powered seizure prediction wearable market research report is one of a series of new reports that provides artificial intelligence-powered seizure prediction wearable market statistics, including artificial intelligence-powered seizure prediction wearable industry global market size, regional shares, competitors with an artificial intelligence-powered seizure prediction wearable market share, detailed artificial intelligence-powered seizure prediction wearable market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence-powered seizure prediction wearable industry. This artificial intelligence-powered seizure prediction wearable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An artificial intelligence (AI)-powered seizure prediction wearable is a smart device equipped with sensors and AI algorithms designed to continuously monitor physiological signals. By analyzing this data in real time, it can predict and alert users to potential epileptic seizures, thereby improving safety, independence, and overall quality of life.

The key product types of AI-powered seizure prediction wearables include wristbands, headbands, smartwatches, patches, and other formats. Wristbands are among the most common, worn on the wrist to track vital parameters such as heart rate, motion, and skin conductance. These devices operate using technologies such as electroencephalography (EEG)-based, accelerometer-based, multi-sensor, and other advanced detection systems. They are available through both online and offline distribution channels and are used across various applications, including hospitals and clinics, home care settings, and research institutions. End users range across different patient groups, including adults, pediatric patients, and the elderly.

The countries covered in the artificial intelligence-powered seizure prediction wearable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence-powered seizure prediction wearable market consists of revenues earned by entities by providing services such as real-time seizure prediction, health monitoring, and data analytics and reporting. The artificial intelligence-powered seizure prediction wearable market also includes sales of smart glasses, necklaces or pendants, and EpiMonitors. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.